Latest News

Recent analysis highlighted that CorVel passed a high-quality investment screen, underpinned by very large returns on invested capital and a debt-free balance sheet in its cost containment and claims management business. This focus on financial strength and operational resilience has drawn attention from investors who prioritize durable business models and conservative balance sheets. Next, we’ll examine how CorVel’s debt-free position shapes its investment narrative in light of the latest...

Merck (MRK) is back on investors’ radar after recent trading left the shares around $115.91, with short term returns mixed, while the past 3 months and year have shown stronger overall performance metrics. See our latest analysis for Merck. Short term share price returns for Merck have been soft, but a 15.56% 90 day share price return and 26.99% 1 year total shareholder return suggest momentum has recently been building for long term holders. If Merck’s moves have you reassessing healthcare,...

Cinemark Holdings (CNK) shares have been relatively steady recently, with a one-month return near flat and a gain of about 4% over the past three months, prompting investors to reassess the cinema operator’s current valuation and earnings profile. See our latest analysis for Cinemark Holdings. At a share price of US$25.53, Cinemark’s recent moves include a 9.63% 7 day share price pullback alongside an 8.50% year to date share price return and a 3 year total shareholder return above 100%. This...

CEO William N. Anderson and his wife recently bought additional Bayer (XTRA:BAYN) shares, increasing their personal stake in the company. The transactions reflect direct insider buying by the top executive at a time when Bayer is dealing with weak earnings and ongoing legal questions. Insider purchases by a CEO are closely watched by investors because they can signal confidence in the company’s prospects and alignment with shareholders. Bayer sits at the crossroads of pharmaceuticals, crop...

CareTrust REIT (CTRE) is drawing fresh attention after its Board of Directors approved a higher quarterly common stock cash dividend, increasing the payout from $0.335 to $0.39 per share. See our latest analysis for CareTrust REIT. The higher dividend comes after a strong run in the shares, with a 90 day share price return of 10.47% and a 1 year total shareholder return of 50.87%, indicating momentum that long term holders have already experienced. If this dividend move has you looking beyond...

Recent commentary around Photronics (PLAB) is being driven by a mix of positives, including record revenue from high-end photomasks and fresh investments in U.S. and South Korean facilities, alongside softer demand, declining sales, and margin pressures. See our latest analysis for Photronics. Despite recent headlines around record high end photomask revenue and new capacity investments, Photronics’ recent share price performance has cooled. The company has a 30 day share price return of...

If you are wondering whether Robinhood Markets at around US$76 per share is priced for perfection or still has room based on fundamentals, you are not alone. The stock has pulled back recently, with a 5.5% decline over the last 7 days and an 11.1% decline over the last 30 days. However, the 1 year return sits at 111.3% and the 3 year gain is very large at around 7x. That swing in sentiment comes as Robinhood stays in the headlines for its role as a major retail trading platform and for...

Wave Life Sciences (WVE) drew investor attention after reporting interim Phase I data for its INHBE obesity candidate WVE-007, and detailing a cash position it expects to fund multiple trials and regulatory milestones through 2026. See our latest analysis for Wave Life Sciences. The latest WVE-007 readout and funding runway arrive after a 1-year total shareholder return of about 30% and a very large 3-year total shareholder return, even as the 90-day share price return of a 19.38% decline and...

Playtika Holding (NasdaqGS:PLTK) announced that Chief Financial Officer and President Craig Abrahams will resign effective April 1, 2026. Tae Lee, who has corporate finance experience at Playtika and Meta, will become acting CFO when the change takes effect. Board Chairperson Robert Antokol will also assume the role of President, taking on an expanded leadership position. Playtika operates in the mobile gaming sector, where user engagement, live operations and content updates tend to matter...

In March 2026, Lasertec drew heightened attention after reports of stronger-than-expected order momentum for its semiconductor inspection and wafer metrology equipment, following a sharp sector-wide selloff tied to inflation concerns. This sequence of macro-driven weakness followed by renewed product-focused interest highlights how quickly sentiment can swing around Lasertec’s core inspection business. We’ll now examine how this stronger-than-expected order momentum for semiconductor...

Sunrun (RUN) is back on investors’ radar after recent trading has highlighted how volatile the stock can be, with sharp swings over the past month and past 3 months drawing fresh scrutiny. See our latest analysis for Sunrun. At a share price of US$11.97, Sunrun’s recent 30 day and year to date share price returns of 42.06% and 38.43% declines sit in contrast with a 1 year total shareholder return of 92.75%. This suggests that earlier optimism has cooled while longer term holders still sit on...

RLX Technology Inc. has reported its full-year 2025 results, with revenue of CNY 3,958.86 million and net income of CNY 921.87 million, alongside higher basic and diluted earnings per share from continuing operations compared with 2024. Over the course of its CNY 330 million share repurchase program completed in 2025, RLX bought back 12.71% of its shares, meaning recent profit growth is now spread across a meaningfully smaller share count. With full-year earnings rising and a sizeable...

TXT e-solutions (BIT:TXT) has just wrapped up FY 2025 with fourth quarter revenue of €112.8 million and basic EPS of €0.70, putting fresh numbers on the table for investors to weigh. The company reported revenue of €84.98 million and EPS of €0.26 in Q4 2024 and €112.8 million and €0.70 in Q4 2025. Trailing twelve month revenue is €394.3 million with EPS of €1.83. For the year, earnings growth of 46.5% and net margin moving from 5.2% to 5.9% give this update a clearly profitability-focused...

Integer Holdings event overview Integer Holdings (ITGR) has drawn fresh attention after recent share price moves, with the stock down about 3% over the past month and up roughly 15% in the past 3 months. See our latest analysis for Integer Holdings. The 1-year total shareholder return decline of 29.65% contrasts with the recent 14.55% 90-day share price return. This suggests momentum has picked up after a weaker stretch for long-term holders at the latest share price of US$83.30. If Integer’s...

If you are wondering whether Asahi Kasei is still good value after its recent run, you are not alone. The key question now is how the current share price lines up with the underlying business. The stock closed at ¥1,616.5, with returns of 13.8% year to date, 60.5% over 1 year, 94.7% over 3 years and 38.5% over 5 years, although it has seen a 5.6% decline over the last 7 days and a 6.9% decline over the last 30 days. Recent news coverage around Asahi Kasei has focused on its position in the...

Fluor (NYSE:FLR) is opening a new office in Bucharest, Romania to support advanced nuclear energy projects in Eastern Europe. The office will focus on major Romanian projects, including the Doicești small modular reactor installation and the expansion of the Cernavodă nuclear power plant. This move reflects Fluor’s broader push into European nuclear infrastructure and clean energy solutions. For you as an investor, the Bucharest office highlights how Fluor is positioning its engineering and...

BridgeBio Pharma recently presented additional positive interim data from its Phase 3 FORTIFY trial of oral BBP-418 in LGMD2I/R9, showing broad efficacy across mobility, biomarker, and subgroup endpoints, along with a safety profile comparable to placebo. These results underpin BridgeBio’s plan to file for US FDA approval in the first half of 2026, positioning BBP-418 as a potential first-ever approved therapy for any form of limb-girdle muscular dystrophy and highlighting the company’s...

Toyota Motor (TSE:7203) is ramping up investment in solid-state battery technology. The company is preparing for potential mass production within the next two years. This push positions Toyota for a possible shift in how electric vehicles are powered and designed. Toyota is best known for its hybrid leadership, and this solid-state battery move adds a new angle to its electric vehicle plans. As global automakers compete to improve driving range, charging times, and battery safety, a...

Merchants Bancorp recently reported quarterly results that exceeded analyst expectations for revenue, earnings per share and net interest income, highlighting continued strength in its low-risk, government-backed lending programs such as multi-family mortgage banking and mortgage warehousing. This earnings beat underscores how the bank’s focus on government-supported credit channels can support business resilience even when broader financial conditions are uncertain. Next, we will examine...

Ryanair Holdings stock after recent performance Ryanair Holdings (ISE:RYA) has drawn fresh attention after recent share performance, with the stock showing a 13.6% decline over the past 3 months and a 13.8% decline year to date. See our latest analysis for Ryanair Holdings. At a share price of €25.61, Ryanair’s recent 30 day share price return of 3.43% decline and 90 day share price return of 13.63% decline suggest fading short term momentum. However, the 1 year total shareholder return of...

Netskope (NTSK) sets the stage with FY 2026 numbers Netskope (NTSK) has just put fresh FY 2026 figures on the table, with fourth quarter revenue at US$196.3 million and a basic EPS loss of US$0.14, alongside a full year basic EPS loss of US$3.18 on trailing twelve month revenue of US$709.0 million. Over recent quarters the company has seen revenue move from US$148.5 million in Q4 FY 2025 to US$196.3 million in Q4 FY 2026, while quarterly basic EPS has ranged from a loss of US$0.72 to a loss...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just cleared a key hurdle in autoimmune drug development, with China’s NMPA approving the IND for SKB575/HBM7575, a long acting bispecific antibody for atopic dermatitis. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The IND approval landed as Sichuan Kelun-Biotech Biopharmaceutical’s 1 day share price return of 1.75% and 7 day share price return of 2.23% contrast with a 30 day share price return of about a 10%...

If you are wondering whether Lattice Semiconductor still offers good value after a strong multi year run, this article will walk through what the numbers are indicating about the stock today. The share price recently closed at US$86.40, with returns of 49.0% over 1 year and 96.4% over 5 years. Over the last 7 and 30 days the share price declined 5.2% and 5.0% respectively, while it has gained 9.9% year to date. Recent coverage of Lattice has focused on its position in the semiconductor space...

Amrize (SWX:AMRZ) is drawing fresh attention after launching its EVERtect high performance concrete range at CONEXPO CON/AGG, pairing this product rollout with recent insider and institutional share purchases. See our latest analysis for Amrize. Despite the EVERtect launch, insider buying and the upcoming AGM, Amrize’s recent momentum has been soft, with a 30-day share price return of a 4.62% decline and a year-to-date share price return of a 2.20% decline from CHF43.52. If this concrete...